The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer's Disease

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Current Neuropharmacology

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.2174/18756190mte3dotygy
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Neuroglial Function and Hormonal Modulation in Neurodegenerative Diseases: The Influence of Sex Hormones

  2026cites this paper
• G Protein‐Coupled Receptor Signaling: Implications and Therapeutic Development Advances in Cancers

  2025cites this paper
• Microglia and Macrophages in Central Nervous System Homeostasis and Disease Progression: Guardians and Executioners

  2025cites this paper
• Cerebrospinal fluid NPTX2 and [18F]FDG PET track serotonergic vulnerability to neurodegeneration in prodromal Alzheimer’s disease

  2025cites this paper
• The Role of Glutamate Receptors in Ischemic Stroke

  2025cites this paper
• Glutamate: Molecular Mechanisms and Signaling Pathway in Alzheimer’s Disease, a Potential Therapeutic Target

  2024cites this paper
• The Alteration of Microglial Calcium Homeostasis in Central Nervous System Disorders: A Comprehensive Review

  2024cites this paper
• The role of N-methyl-D-aspartate glutamate receptors in Alzheimer's disease: from pathophysiology to therapeutic approaches.

  2023cites this paper
• Understanding Brain Diseases: From Receptor Dysregulation to Neurodegeneration, Neuroinflammation and Memory Impairment

  2023cites this paper
• Effect of Probiotic Therapy on Neuropsychiatric Manifestations in Children with Multiple Neurotransmitter Disorders: A Study

  2023cites this paper
• Paeoniflorin improves cognitive dysfunction, restores glutamate receptors, attenuates gliosis and maintains synaptic plasticity in cadmium-intoxicated mice

  2022cites this paper
• Phosphorylation and regulation of group II metabotropic glutamate receptors (mGlu2/3) in neurons

  2022cites this paper
• Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases.

  2022cites this paper
• Metabotropic Glutamate Receptor 5 Antagonism Reduces Pathology and Differentially Improves Symptoms in Male and Female Heterozygous zQ175 Huntington’s Mice

  2022cites this paper
• A positive allosteric modulator for the muscarinic receptor (M1 mAChR) improves pathology and cognitive deficits in female APPswe/PSEN1ΔE9 mice

  2021cites this paper